Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 2 Thoracic 1 Dermatologic 1 CNS 1

Conditions

Carcinoma, Non-Small-Cell Lung 1

Interventions

Carboplatin 347 pembrolizumab 322 Pemetrexed 246 Cisplatin 218 Paclitaxel 147 Nivolumab 138 durvalumab 133 osimertinib 112 Docetaxel 111 atezolizumab 109 Specimen Handling 91 Radiotherapy 87 Drug Therapy 85 Magnetic Resonance Spectroscopy 77 Etoposide 76 Radiosurgery 72 Gemcitabine 71 Ipilimumab 55 130-nm albumin-bound paclitaxel 54 Bevacizumab 52 cemiplimab 47 tislelizumab 44 Blood Specimen Collection 40 Cetuximab 35 Taxes 34 Platinum 33 Injections 33 Biopsy 33 Standard of Care 31 Immunoglobulin G 30

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

HBI-8000 × Thoracic × 1 year × Clear all

NCT05141357 2025-12-24

HBI-8000

HUYABIO International, LLC.

Phase 2 Terminated

5 enrolled 8 charts

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡